Altogether, our data identify Dnmt3a as a critical tumor suppressor gene in the prevention of B- and T cell malignancies and link decreased Dnmt3a levels to decrease in p53, which may functionally contribute to the development of CD8+ PTCL. This evidence concerns the gene TP53 and mature T-cell and NK-cell non-Hodgkin lymphoma.